Article
Hepatocellular carcinoma: Towards personalized medicine
16 Feb 2012
Abstract excerpt
Over the past several years, the success of genome-wide association studies (GWAS) and pharmacogenomics has gradually begun to enable personalized medicine in some fields. In the field of liver diseases, host genetic factors are now very useful in clinical practice for predicting treatment outcome and adverse reactions for pegylated interferon plus ribavirin combination therapy against chronic hepatitis C virus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
